BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

305 related articles for article (PubMed ID: 22681248)

  • 1. Allosteric modulation of protease-activated receptor signaling.
    Canto I; Soh UJ; Trejo J
    Mini Rev Med Chem; 2012 Aug; 12(9):804-11. PubMed ID: 22681248
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cofactoring and dimerization of proteinase-activated receptors.
    Lin H; Liu AP; Smith TH; Trejo J
    Pharmacol Rev; 2013; 65(4):1198-213. PubMed ID: 24064459
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protease-activated receptors in hemostasis.
    Nieman MT
    Blood; 2016 Jul; 128(2):169-77. PubMed ID: 27127302
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endosomal signaling by protease-activated receptors.
    Grimsey N; Lin H; Trejo J
    Methods Enzymol; 2014; 535():389-401. PubMed ID: 24377935
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The domino effect triggered by the tethered ligand of the protease activated receptors.
    Han X; Nieman MT
    Thromb Res; 2020 Dec; 196():87-98. PubMed ID: 32853981
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of protease-activated receptor signaling by post-translational modifications.
    Grimsey N; Soto AG; Trejo J
    IUBMB Life; 2011 Jun; 63(6):403-11. PubMed ID: 21438117
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biased signalling and proteinase-activated receptors (PARs): targeting inflammatory disease.
    Hollenberg MD; Mihara K; Polley D; Suen JY; Han A; Fairlie DP; Ramachandran R
    Br J Pharmacol; 2014 Mar; 171(5):1180-94. PubMed ID: 24354792
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Progress in the understanding of protease-activated receptors.
    Gabazza EC; Taguchi O; Kamada H; Hayashi T; Adachi Y; Suzuki K
    Int J Hematol; 2004 Feb; 79(2):117-22. PubMed ID: 15005337
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protease-activated receptors: new concepts in regulation of G protein-coupled receptor signaling and trafficking.
    Trejo J
    J Pharmacol Exp Ther; 2003 Nov; 307(2):437-42. PubMed ID: 12966163
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proteolysis of the exodomain of recombinant protease-activated receptors: prediction of receptor activation or inactivation by MALDI mass spectrometry.
    Loew D; Perrault C; Morales M; Moog S; Ravanat C; Schuhler S; Arcone R; Pietropaolo C; Cazenave JP; van Dorsselaer A; Lanza F
    Biochemistry; 2000 Sep; 39(35):10812-22. PubMed ID: 10978167
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proteinase-activated receptors (PARs)--the PAR3 Neo-N-terminal peptide TFRGAP interacts with PAR1.
    Kaufmann R; Schulze B; Krause G; Mayr LM; Settmacher U; Henklein P
    Regul Pept; 2005 Feb; 125(1-3):61-6. PubMed ID: 15582715
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The multiple layers of signaling selectivity at protease-activated receptors.
    Kyriazis I; Ellul J; Katsakiori P; Panayiotakopoulos G; Flordellis C
    Curr Pharm Des; 2012; 18(2):161-74. PubMed ID: 22229576
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protease-activated receptors - biology and role in cancer.
    Hempel D; Sierko E; Wojtukiewicz MZ
    Postepy Hig Med Dosw (Online); 2016 Jul; 70(0):775-86. PubMed ID: 27383574
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular basis for activation and biased signaling at the thrombin-activated GPCR proteinase activated receptor-4 (PAR4).
    Thibeault PE; LeSarge JC; Arends D; Fernandes M; Chidiac P; Stathopulos PB; Luyt LG; Ramachandran R
    J Biol Chem; 2020 Feb; 295(8):2520-2540. PubMed ID: 31892516
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thrombin and protease-activated receptors (PARs) in atherothrombosis.
    Martorell L; Martínez-González J; Rodríguez C; Gentile M; Calvayrac O; Badimon L
    Thromb Haemost; 2008 Feb; 99(2):305-15. PubMed ID: 18278179
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Challenges and Opportunities in Protease-Activated Receptor Drug Development.
    Hamilton JR; Trejo J
    Annu Rev Pharmacol Toxicol; 2017 Jan; 57():349-373. PubMed ID: 27618736
    [TBL] [Abstract][Full Text] [Related]  

  • 17. How the protease thrombin talks to cells.
    Coughlin SR
    Proc Natl Acad Sci U S A; 1999 Sep; 96(20):11023-7. PubMed ID: 10500117
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protease-activated receptors in neuronal development, neurodegeneration, and neuroprotection: thrombin as signaling molecule in the brain.
    Rohatgi T; Sedehizade F; Reymann KG; Reiser G
    Neuroscientist; 2004 Dec; 10(6):501-12. PubMed ID: 15534036
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proteinase-activated receptors (PARs) - focus on receptor-receptor-interactions and their physiological and pathophysiological impact.
    Gieseler F; Ungefroren H; Settmacher U; Hollenberg MD; Kaufmann R
    Cell Commun Signal; 2013 Nov; 11():86. PubMed ID: 24215724
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential signaling by protease-activated receptors: implications for therapeutic targeting.
    Sidhu TS; French SL; Hamilton JR
    Int J Mol Sci; 2014 Apr; 15(4):6169-83. PubMed ID: 24733067
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.